Various studies have been conducted on the use of adjuvant therapy in colon cancer, including the effectiveness of different chemotherapy regimens and the impact of patient factors on recurrence risk and survival outcomes. Molecular markers have also been identified to classify subtypes of stage III colon cancer. Monitoring of colorectal cancer using 18FDG-PET/CT has been studied in a randomized trial.